Company profile for CareDx

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are committed to improving transplant patient outcomes by providing innovative and intelligent solutions throughout the entire patient journey. Our understanding of transplant patients and care teams allows us to develop solutions to extend graft life. With two decades of commitment to transplant care, we have developed close partnerships across the transplant ecosystem that grow stronger every day. CareDx is committed to i...
We are committed to improving transplant patient outcomes by providing innovative and intelligent solutions throughout the entire patient journey. Our understanding of transplant patients and care teams allows us to develop solutions to extend graft life. With two decades of commitment to transplant care, we have developed close partnerships across the transplant ecosystem that grow stronger every day. CareDx is committed to improving patient outcomes across the transplant journey. As part of this mission, we enter into strategic partnerships and alliances with global medical institutions, hospital ecosystems, and biopharmaceutical.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1 Tower Pl, 9th Floor South San Francisco, CA 94080
Telephone
Telephone
1-888-255-6627
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

BioProcess International US West

Not Confirmed

envelop Contact Supplier

BioProcess International US West

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20260227366737/en/CareDx-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

BUSINESSWIRE
27 Feb 2026

https://www.businesswire.com/news/home/20260218713403/en/CareDx-to-Participate-in-the-Raymond-James-47th-Annual-Institutional-Investors-Conference

BUSINESSWIRE
18 Feb 2026

https://www.businesswire.com/news/home/20260212430487/en/CareDx-Announces-Clinical-Validation-Results-for-AlloHeme-the-First-AIPowered-NGS-Surveillance-Solution-for-AML-and-MDS-PostCell-Therapy

BUSINESSWIRE
12 Feb 2026

https://www.businesswire.com/news/home/20260210145919/en/CareDx-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-24-2026

BUSINESSWIRE
10 Feb 2026

https://www.businesswire.com/news/home/20260203634748/en/CareDx-to-Present-AlloHeme-Pivotal-Clinical-Validation-Data-in-Hematologic-Cancer-Relapse-Detection-at-2026-Tandem-Meetings

BUSINESSWIRE
03 Feb 2026

https://www.businesswire.com/news/home/20260107073051/en/CareDx-and-10x-Genomics-to-Launch-ImmuneScape-Program-A-Multiomics-Research-Platform-to-Decode-Transplant-Rejection-and-Drug-Response

BUSINESSWIRE
07 Jan 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty